Zhang J M, Xu X M, Wang Y F, Liu S G, Li Q, Sun L
Institute of Immunization Program Management, Hebei Provincial Center for Disease Control and Prevention,Shijiazhuang 050021, China.
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 May 6;56(5):595-600. doi: 10.3760/cma.j.cn112150-20210625-00609.
To compare the immunogenicity of three kinds immunization programs with poliovirus vaccine. Healthy infants aged 2 months or over were selected and divided into three groups by complete randomization method. Basic immunization with Sabin inactivated poliovirus vaccine(sIPV) and bivalent oral poliovirus vaccine(bOPV) were completed. Three kinds of basic immunization procedures were 1sIPV+2bOPV,2sIPV+1bOPV and 3sIPV, respectively.Two qualified serums that before basic immunization and 28-42 days later were collected, and measured the poliovirus neutralizing antibody with microcell neutralization method. To compare the difference by analysis of variance, rank test and χ test. After the basic immunization, 205 subjects of the positive conversion rate of poliovirus neutralizing antibodies of types Ⅰ, Ⅱ and Ⅲwere all higher than 97.00%, and the positive rates were all higher than 98.00%, the geometric mean titer (GMT) of neutralizing antibody was significantly higher than that before basic immunization in three groups.There were significant differences in the positive rate and GMT before and after basic immunization of typeⅠ, Ⅱand Ⅲ in the three (<0.05). The highest GMT in three groups after basic immunization were all typeⅠ, followed by type Ⅲ, and the lowest in type Ⅱ. The GMT of type Ⅱin 2sIPV+1bOPV and 3sIPV groups were both higher than that in sIPV+2bOPV group. After three kinds of basic immunization, the poliovirus neutralizing antibodies of serum were all at high levels in three groups, which could form an effective immune barrier against poliovirus. The immunogenicity of three kinds of basic immunization programs were all well, but there were certain differences of neutralizing antibodies among three kinds basic immunization programs. The immunogenicity in 2sIPV+1bOPV and 3sIPV groups against typeⅡpoliovirus were better than that in 1sIPV+2bOPV group.
比较三种脊髓灰质炎疫苗免疫程序的免疫原性。选取2月龄及以上健康婴儿,采用完全随机化方法分为三组。完成了脊髓灰质炎灭活疫苗(sIPV)和二价口服脊髓灰质炎疫苗(bOPV)的基础免疫。三种基础免疫程序分别为1剂sIPV+2剂bOPV、2剂sIPV+1剂bOPV和3剂sIPV。采集基础免疫前及28-42天后两份合格血清,采用微量细胞中和法检测脊髓灰质炎病毒中和抗体。通过方差分析、秩和检验及χ检验比较差异。基础免疫后,Ⅰ、Ⅱ、Ⅲ型脊髓灰质炎病毒中和抗体阳转率205例均高于97.00%,阳性率均高于98.00%,三组中和抗体几何平均滴度(GMT)均显著高于基础免疫前。三组Ⅰ、Ⅱ、Ⅲ型基础免疫前后阳性率及GMT差异均有统计学意义(<0.05)。三组基础免疫后GMT最高的均为Ⅰ型,其次为Ⅲ型,Ⅱ型最低。2剂sIPV+1剂bOPV组和3剂sIPV组Ⅱ型GMT均高于1剂sIPV+2剂bOPV组。三种基础免疫后,三组血清脊髓灰质炎病毒中和抗体均处于较高水平,均可形成有效的脊髓灰质炎病毒免疫屏障。三种基础免疫程序免疫原性均良好,但三种基础免疫程序中和抗体存在一定差异。2剂sIPV+1剂bOPV组和3剂sIPV组针对Ⅱ型脊髓灰质炎病毒的免疫原性优于1剂sIPV+2剂bOPV组。